Unlocking UK Biobank’s Data Potential

28 Jan 2026
Biodata Stage
  • Explore the latest in proteomics, sequencing, and cloud-based analysis (RAP) 

  • Hear how UK Biobank’s resources are evolving to support cutting-edge research 

  • Discover applications in disease mechanisms, biomarkers, and population genomics 

  • Gain a forward-looking view on scalable data-driven discovery 

Speakers
Mark Effingham
Mark Effingham, Deputy CEO - UK Biobank